Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases

Additional Metadata
Keywords	Combined modality treatment, Isolated lung perfusion, Local control, Lung metastases, Survival
Persistent URL	doi.org/10.1097/JTO.0000000000000279, hdl.handle.net/1765/84514
Journal	Journal of Thoracic Oncology
Organisation	Department of Cardio-Thoracic Surgery
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Den Hengst, W. A., Hendriks, J. M. H., Balduyck, B., Rodrigus, I., Vermorken, J., Lardon, F., Versteegh, M., Braun, J., Gelderblom, H., Schramel, F., van Boven, W.-J., van Putte, B., Birim, O., Maat, A. P. W. M.& van Schil, P. (2014). Phase II multicenter clinical trial of pulmonary metastasectomy and isolated lung perfusion with melphalan in patients with resectable lung metastases. Journal of Thoracic Oncology, 9(10), 1547–1553.https://doi.org/10.1097/JTO.0000000000000279

Publication